Companies / RxSight, Inc. / Activity
Activity — RxSight, Inc.
27 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 28, 2026 | Wilterding Mark Executive | Other | Common Stock | $61.4K | -8K -39.47% | 12,373 0.03% of shares | low |
| Apr 17, 2026 | Goldshleger Ilya Executive | Exercise | Common Stock | $51.6K | +12K +19.01% | 78,180 0.19% of shares | low |
| Feb 28, 2026 | Gaines Scott Executive | Other | Common Stock | $19.6K | -3K -14.80% | 14,848 0.04% of shares | low |
| Jun 17, 2026 | Warner Robert Keith Director | Grant | Common Stock | — | +37K +90.25% | 78,076 0.19% of shares | low |
| Jun 17, 2026 | Palmisano Robert J Director | Grant | Common Stock | — | +37K +90.25% | 78,076 0.19% of shares | low |
| Jun 17, 2026 | Maniar Shweta Director | Grant | Common Stock | — | +37K +204.23% | 55,172 0.13% of shares | low |
| Jun 17, 2026 | Fountain Tamara Director | Grant | Common Stock | — | +37K +104.20% | 72,582 0.17% of shares | low |
| Jun 17, 2026 | Link William J Phd Director | Grant | Common Stock | — | +37K +97.84% | 74,892 0.18% of shares | low |
| Jun 17, 2026 | Corley Jesse Anderson Director | Grant | Common Stock | — | +37K +75.29% | 86,227 0.21% of shares | low |
| Jun 17, 2026 | Cohen Raymond W Director | Grant | Common Stock | — | +31K +86.53% | 66,532 0.16% of shares | low |
| Jun 17, 2026 | Tammenoms Bakker Juliet Director | Grant | Common Stock | — | +37K +76.93% | 85,183 0.20% of shares | low |
| Jun 17, 2026 | Andrews Julie Director | Grant | Common Stock | — | +37K +90.25% | 78,076 0.19% of shares | low |
| Apr 17, 2026 | Goldshleger Ilya Executive | Exercise | Stock Option (right to buy) | — | -12K -99.96% | 5 <0.01% of shares | low |
| Feb 27, 2026 | Weinberg Eric Executive | Grant | Restricted Stock Unit | — | +32K | 32,218 0.08% of shares | low |
| Feb 27, 2026 | Kurtz Ronald M MD CEO | Grant | Restricted Stock Unit | — | +81K | 80,545 0.19% of shares | low |
| Feb 28, 2026 | Wilterding Mark Executive | Exercise | Restricted Stock Unit | — | -20K -12.50% | 143,087 0.34% of shares | low |
| Feb 28, 2026 | Wilterding Mark Executive | Exercise | Common Stock | — | +20K | 20,441 0.05% of shares | low |
| Feb 28, 2026 | Gaines Scott Executive | Exercise | Restricted Stock Unit | — | -1K -33.33% | 2,500 <0.01% of shares | low |
| Feb 28, 2026 | Gaines Scott Executive | Exercise | Restricted Stock Unit | — | -2K -14.29% | 9,936 0.02% of shares | low |
| Feb 28, 2026 | Gaines Scott Executive | Exercise | Restricted Stock Unit | — | -1K -16.67% | 6,250 0.02% of shares | low |
| Feb 28, 2026 | Gaines Scott Executive | Exercise | Restricted Stock Unit | — | -604 -20.01% | 2,414 <0.01% of shares | low |
| Feb 28, 2026 | Gaines Scott Executive | Exercise | Restricted Stock Unit | — | -2K -33.33% | 3,000 <0.01% of shares | low |
| Feb 27, 2026 | Gaines Scott Executive | Grant | Restricted Stock Unit | — | +32K | 32,218 0.08% of shares | low |
| Feb 28, 2026 | Gaines Scott Executive | Exercise | Common Stock | — | +6K +56.07% | 17,428 0.04% of shares | low |
| Feb 27, 2026 | Goldshleger Ilya Executive | Grant | Restricted Stock Unit | — | +32K | 32,218 0.08% of shares | low |
| Jan 12, 2026 | Wilterding Mark Executive | Grant | Restricted Stock Unit | — | +164K | 163,528 0.39% of shares | low |
| Jan 12, 2026 | Wilterding Mark Executive | Grant | Stock Option (right to buy) | — | +259K | 258,770 0.62% of shares | low |